Why the Cynata Therapeutics share price is up 10% today

Here's why the Cynata Therapeutics Ltd (ASX: CYP) share price has jumped 9.8% today

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Cynata Therapeutics Ltd (ASX: CYP) share price has jumped 9.8% after opening today, with CYP shares trading at $1.11 at the time of writing. Cynata shares had closed at $1.02 yesterday before opening at $1.10 this morning and moving higher still after open.

Cynata Therapeutics is a Australian stem cell and regenerative medicine company. After today's moves it is valued at approximately $115 million.

Why have Cynata shares moved?

Today's gains can be attributed to the company releasing some positive data on the preclinical drug trial results of its Cymerus treatment. Cynata hopes Cymerus will be used in the effective treatment of sepsis (sometimes called 'blood poisoning'), a life-threatening disease that arises from the body's response to harm or infection. The company noted that sepsis is "a major medical challenge and the most common cause of death in hospital intensive care units."

The company noted that in its trials, Cymerus mesenchymal stem cells successfully increased blood oxygen levels, improved lung health and decreased inflammation. The trials were co-funded by and conducted in partnership with the Royal College of Surgeons in Ireland.

Cynata's Chief Operating Officer Dr Kilian Kelly described the trial results as "highly encouraging" and stated: 

We believe the data can support progression to a clinical trial in patients with sepsis. These latest results build on our broad preclinical database across a range of commercial opportunities, including asthma, heart disease and diabetes complications.

Cynata shares have fallen steeply since reaching their 52-week high back in late July of this year. Even after today's share price moves, CYP shares are still trading toward the lower end of the company's 52-week range ($0.94–1.87) and just shy of its year-to-date low.

Should you invest $1,000 in Cynata Therapeutics Limited right now?

Before you buy Cynata Therapeutics Limited shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Cynata Therapeutics Limited wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 5 December 2024

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A man looking at his laptop and thinking.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors ended up snatching defeat from the jaws of victory today.

Read more »

Dollar sign in yellow with a red falling arrow in front of a graph, symbolising a falling share price.
Materials Shares

Ouch: The Pilbara Minerals share price just hit a multi-year low

It's been a tough day for lithium investors.

Read more »

Three hikers lift their arms in jubilation as they reach a rocky peak overlooking a sensational view of water and mountains with a blue sky surrounding them.
52-Week Highs

3 blue chip ASX 200 shares smashing new highs on Wednesday

These names are finishing the year strongly.

Read more »

Excited group of friends sitting on sofa watching sports on TV and celebrating.
Share Gainers

Why Clarity, Omni Bridgeway, Santana Minerals, and Vulcan shares are pushing higher today

These shares are having a good time on hump day. But why?

Read more »

a woman holds her hands to her temples as she sits in front of a computer screen with a concerned look on her face.
Share Fallers

Why Capricorn Metals, Insignia, Sayona Mining, and Southern Cross Gold shares are falling today

These shares are having a tough time on hump day. But why?

Read more »

Man with rocket wings which have flames coming out of them.
Share Gainers

Guess which ASX All Ords stock just rocketed 44%

Investors are sending the ASX All Ords stock racing higher today. But why?

Read more »

Three people in a corporate office pour over a tablet, ready to invest.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A young entrepreneur boy catching money at his desk, indicating growth in the ASX share price or dividends
Share Market News

2 millionaire-maker US artificial intelligence (AI) stocks

These two stocks could be huge winners as machine-learning technology helps grow the AI industry over the coming years.

Read more »